[Clinical aspects of anticholinergic agents].
Friedman
M
M
D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000627:therapeutic use; D001991:Bronchitis / Q000188:drug therapy; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D018680:Cholinergic Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D002908:Chronic Disease; D017281:Cost of Illness; D004338:Drug Combinations; D004357:Drug Synergism; D006801:Humans; D009241:Ipratropium / Q000008:administration & dosage / Q000627:therapeutic use; D008173:Lung Diseases, Obstructive / Q000188:drug therapy* / Q000191:economics / Q000503:physiopathology; D018727:Muscarinic Antagonists / Q000008:administration & dosage / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D018680:Cholinergic Antagonists; D004338:Drug Combinations; D018727:Muscarinic Antagonists; D009241:Ipratropium